Beijing Immupeutics Medicine Technology Limited
1 clinical trials · Sponsor
◉ Watch Beijing Immupeutics Medicine Technology Limited
| Record | Firm | Date |
|---|---|---|
| A Study of IPM514 in Patients With Esophageal Squamous Cell Carcinoma. (NCT07203898) | Beijing Immupeutics Medicine Technology Limited | 2026-06-30 |
Track Beijing Immupeutics Medicine Technology Limited automatically
Every clearance here is in the API, with alerts when new ones post.